202 related articles for article (PubMed ID: 29363720)
1. Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway.
Shi H; Bi H; Sun X; Dong H; Jiang Y; Mu H; Liu G; Kong W; Gao R; Su J
Mol Med Rep; 2018 Mar; 17(3):4327-4336. PubMed ID: 29363720
[TBL] [Abstract][Full Text] [Related]
2. Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells.
Zhang Y; Xu X; He P
Mol Med Rep; 2011; 4(1):25-9. PubMed ID: 21461558
[TBL] [Abstract][Full Text] [Related]
3. Tubeimoside-1 inhibits the proliferation and metastasis by promoting miR-126-5p expression in non-small cell lung cancer cells.
Shi H; Bi H; Sun X; Dong H; Jiang Y; Mu H; Li W; Liu G; Gao R; Su J
Oncol Lett; 2018 Sep; 16(3):3126-3134. PubMed ID: 30127904
[TBL] [Abstract][Full Text] [Related]
4. Tubeimoside-1 (TBMS1) inhibits lung cancer cell growth and induces cells apoptosis through activation of MAPK-JNK pathway.
Hao W; Wang S; Zhou Z
Int J Clin Exp Pathol; 2015; 8(10):12075-83. PubMed ID: 26722392
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of tubeimoside I in human choriocarcinoma JEG-3 cells by induction of cytochrome c release and apoptosis via the mitochondrial-related signaling pathway.
Huang P; Yu C; Liu XQ; Ding YB; Wang YX; He JL
Int J Mol Med; 2011 Oct; 28(4):579-87. PubMed ID: 21687933
[TBL] [Abstract][Full Text] [Related]
6. Tubeimoside-1 induces oxidative stress-mediated apoptosis and G0/G1 phase arrest in human prostate carcinoma cells in vitro.
Yang JB; Khan M; He YY; Yao M; Li YM; Gao HW; Ma TH
Acta Pharmacol Sin; 2016 Jul; 37(7):950-62. PubMed ID: 27292614
[TBL] [Abstract][Full Text] [Related]
7. Tubeimoside-1, a triterpenoid saponin, induces cytoprotective autophagy in human breast cancer cells in vitro via Akt-mediated pathway.
Jiang SL; Guan YD; Chen XS; Ge P; Wang XL; Lao YZ; Xiao SS; Zhang Y; Yang JM; Xu XJ; Cao DS; Cheng Y
Acta Pharmacol Sin; 2019 Jul; 40(7):919-928. PubMed ID: 30315250
[TBL] [Abstract][Full Text] [Related]
8. Tubeimoside‑1 induces apoptosis in human glioma U251 cells by suppressing PI3K/Akt‑mediated signaling pathways.
Cao LJ; Xie HT; Chu ZX; Ma Y; Wang MM; Shi Z
Mol Med Rep; 2020 Aug; 22(2):1527-1535. PubMed ID: 32627020
[TBL] [Abstract][Full Text] [Related]
9. Multiple pathways were involved in tubeimoside-1-induced cytotoxicity of HeLa cells.
Xu Y; Ching YP; Zhou Y; Chiu JF; Chen F; He QY
J Proteomics; 2011 Dec; 75(2):491-501. PubMed ID: 21903181
[TBL] [Abstract][Full Text] [Related]
10. Tubeimoside-1 inhibits the growth and invasion of colorectal cancer cells through the Wnt/β-catenin signaling pathway.
Bian Q; Liu P; Gu J; Song B
Int J Clin Exp Pathol; 2015; 8(10):12517-24. PubMed ID: 26722439
[TBL] [Abstract][Full Text] [Related]
11. Tubeimoside-1 exerts cytotoxicity in HeLa cells through mitochondrial dysfunction and endoplasmic reticulum stress pathways.
Xu Y; Chiu JF; He QY; Chen F
J Proteome Res; 2009 Mar; 8(3):1585-93. PubMed ID: 19215086
[TBL] [Abstract][Full Text] [Related]
12. Role of mitochondria and mitochondrial cytochrome c in tubeimoside I-mediated apoptosis of human cervical carcinoma HeLa cell line.
Wang F; Ma R; Yu L
Cancer Chemother Pharmacol; 2006 Feb; 57(3):389-99. PubMed ID: 16172906
[TBL] [Abstract][Full Text] [Related]
13. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
14. Tubeimoside-1 induces G2/M phase arrest and apoptosis in SKOV-3 cells through increase of intracellular Ca²⁺ and caspase-dependent signaling pathways.
Chen WJ; Yu C; Yang Z; He JL; Yin J; Liu HZ; Liu HT; Wang YX
Int J Oncol; 2012 Feb; 40(2):535-43. PubMed ID: 21971569
[TBL] [Abstract][Full Text] [Related]
15. Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin.
Ma R; Song G; You W; Yu L; Su W; Liao M; Zhang Y; Huang L; Zhang X; Yu T
Cancer Chemother Pharmacol; 2008 Sep; 62(4):559-68. PubMed ID: 18030471
[TBL] [Abstract][Full Text] [Related]
16. Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model.
Gu Y; Körbel C; Scheuer C; Nenicu A; Menger MD; Laschke MW
Oncotarget; 2016 Feb; 7(5):5258-72. PubMed ID: 26701724
[TBL] [Abstract][Full Text] [Related]
17. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
[TBL] [Abstract][Full Text] [Related]
18. Introduction of exogenous wild‑type p53 mediates the regulation of oncoprotein 18/stathmin signaling via nuclear factor‑κB in non‑small cell lung cancer NCI‑H1299 cells.
Chen S; Zhao Y; Shen F; Long D; Yu T; Lin X
Oncol Rep; 2019 Mar; 41(3):2051-2059. PubMed ID: 30628717
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
20. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
